Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"

Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk

Intuitive Venture PartnersApril 17, 20242024, Serve Robotics

Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in

Intuitive Venture PartnersApril 8, 20242024, entera bio

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader

Intuitive Venture PartnersMarch 26, 20242024, entera bio

Lumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meeting

Lumicell Inc., a privately held company focused on

Intuitive Venture PartnersMarch 26, 20242024, Lumicell

Lumicell Announces FDA Advisory Committee’s Positive Recommendation on the Benefit-Risk Profile of LUMISIGHT™ in the Detection of Cancerous Tissue During Breast Conserving Surgery

Lumicell, Inc., a privately held company focused on innovative

Intuitive Venture PartnersMarch 6, 2024Lumicell, 2024

Lumicell Announces Initial Data Demonstrating LUMISIGHT™’s Ability to Detect Tumors Metastasized to Multiple Organs in the Peritoneum

Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced

Intuitive Venture PartnersMarch 4, 20242024, Lumicell

Aeluma Wins Funding Award from the Department of Energy

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersFebruary 13, 20242024, aeluma

Aeluma Wins Funding Award from the Office of the Secretary of Defense

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersFebruary 8, 2024aeluma, 2024

Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides

Intuitive Venture PartnersDecember 26, 20232023, entera bio

Aeluma Appoints Seasoned Semiconductor Industry Executive Craig Ensley to its Board of Directors

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersDecember 21, 2023aeluma, 2023

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides

Intuitive Venture PartnersNovember 30, 2023entera bio, 2023

Aeluma Wins Second Navy Award

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersNovember 28, 2023Aeluma, 2023

Aeluma Awarded Navy Funding to Develop Photonics Reliability Methodologies for Defense and Aerospace Applications

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersNovember 2, 2023aeluma, 2023

Aeluma Hub Leader USC Named Recipient of CHIPS Act Microelectronics Commons Award

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective technologies for

Intuitive Venture PartnersSeptember 26, 2023aeluma, 2023

Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes

Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK,

Intuitive Venture PartnersSeptember 12, 2023entera bio, 2023

Guerilla RF Announces First Production PO For Satcom Market Securing Stronger Second Half 2023

Guerrilla RF, Inc. (OTCQX: GUER), a leading provider of state-of-the-art radio frequency and microwave

Lori TullmanSeptember 8, 2023guerrilla, 2023

Augmedix Announces Expanding Coverage in Behavioral Health Field for Acute and Ambulatory Care Settings

Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical

Intuitive Venture PartnersSeptember 6, 2023Augmedix, 2023

Serve Robotics Inc. Announces Go-Public Transaction and $30 Million Financing to Support Scaling of Robotic Delivery

Serve Robotics, Inc. (“the Company” or “Serve”), the leading autonomous sidewalk delivery company, today a

Intuitive Venture PartnersAugust 25, 2023Serve Robotics, 2023

Aeluma, Inc. Closes $6 Million Oversubscribed Common Stock Only Private Placement

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in scalable, cost-effective sensor technologies

Intuitive Venture PartnersMay 12, 20232023, Aeluma

Lumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy

Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer

Intuitive Venture PartnersMay 8, 2023Lumicell, 2023